Breaking News
Investing Pro 0
Black Friday SALE: Up to 54% OFF InvestingPro+ CLAIM OFFER

Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session

Stock Markets Sep 27, 2022 18:10
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session
 
IXIC
-0.52%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
BLPH
+0.92%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Gainers

  • Avenue Therapeutics, Inc. (NASDAQ: ATXI) shares surged 159.9% to $9.15. Avenue Therapeutics recently received the official meeting minutes from the FDA regarding a meeting conducted for IV Tramadol in combination with other opioid analgesics to manage moderate-to-moderately severe pain. Concurrently, Avenue Therapeutics announced that it would effect a 1-for-15 reverse stock split.
  • PaxMedica, Inc. (NASDAQ: PXMD) jumped 53.5% to $3.33 as the company issued a corporate update after IPO. The company named Stephen D. Sheldon as CFO.
  • Scienjoy Holding Corporation (NASDAQ: SJ) surged 33.4% to $2.2281 after declining 44% on Monday.
  • InMed Pharmaceuticals Inc. (NASDAQ: INM) gained 28% to $6.54. InMed recently reported a FY22 net loss of $33.17 per share.
  • Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) jumped 24% to $1.2001. Bellerophon announced FDA acceptance of change to ongoing Phase 3 REBUILD study of INOpulse for the treatment of fibrotic interstitial lung disease.
  • FingerMotion, Inc. (NASDAQ: FNGR) gained 23% to $0.9999 after rising around 20% on Monday.
  • Intelligent Living Application Group Inc. (NASDAQ: ILAG) rose 21.6% to $2.48 after gaining over 11% on Monday.
  • Grove Collaborative Holdings, Inc. (NYSE: GROV) shares climbed 21.3% to $3.5901. Grove Collaborative continued retail expansion with entry into thousands of more stores.
  • Unico American Corporation (NASDAQ: UNAM) gained 20.8% to $1.5099.
  • 9 Meters Biopharma, Inc. (NASDAQ: NMTR) rose 20.3% to $0.2490 after the company disclosed final results from Phase 2 VIBRANT study, End-of-Phase 2 meeting with the FDA for Vurolenatide in short bowel syndrome.
  • Milestone Scientific Inc. (NASDAQ: MLSS) gained 20% to $0.8193.
  • Avalon GloboCare Corp. (NASDAQ: AVCO) jumped 19.8% to $0.5271.
  • Pyxis Oncology, Inc. (NASDAQ: PYXS) gained 19.8% to $2.30.
  • Biocept, Inc. (NASDAQ: BIOC) gained 17.1% to $0.9368.
  • Equillium, Inc. (NASDAQ: EQ) jumped 15.5% to $2.23. Equillium announced interim results from the Type B portion of the EQUALISE study evaluating itolizumab in patients with lupus nephritis (LN).
  • Foghorn Therapeutics Inc. (NASDAQ: FHTX) rose 14.1% to $8.67.
  • The Beauty Health Company (NASDAQ: SKIN) gained 12.6% to $11.71 after the company announced a $200 million buyback.
  • Stryve Foods, Inc. (NASDAQ: SNAX) jumped 12% to $0.45.
  • Skillz Inc. (NYSE: SKLZ) jumped 11.9% to $1.0750.
  • Verve Therapeutics, Inc. (NASDAQ: VERV) gained 11.5% to $34.73.
  • BitNile Holdings, Inc. (NYSE: NILE) rose 10.6% to $0.2047.
  • CVR Energy, Inc. (NYSE: CVI) gained 8.2% to $27.65.
  • BIT Mining Limited (NYSE: BTCM) rose 7.7% to $0.28 after declining around 9% on Monday.
  • Novavax, Inc. (NASDAQ: NVAX) gained 7.5% to $20.28. Novavax announced an initial one million doses of Nuvaxovid are available for use in the UK.

Losers

  • FedNat Holding Company (NASDAQ: FNHC) fell 19.9% to $0.18 after dropping over 15% on Monday.
  • Eve Holding, Inc. (NYSE: EVEX) dropped 18% to $10.08. BLADE India signed non-binding order for up to 200 eVTOL vehicles from Eve Air Mobility.
  • Polar Power, Inc. (NASDAQ: POLA) fell 15.2% to $2.68 after gaining around 25% on Monday.
  • Avidity Biosciences, Inc. (NASDAQ: RNA) shares fell 14.9% to $15.95. The FDA has placed a partial clinical hold on new participant enrollment in Avidity Biosciences’ Phase 1/2 MARINA trial of AOC 1001 in adults with myotonic dystrophy type 1 (DM1).
  • Evaxion Biotech A/S (NASDAQ: EVAX) fell 14.9% to $2.34. Evaxion Biotech recently announced it reached an important milestone announcing today that it had enrolled its first patient in the global phase 2b clinical trial of EVX-01.
  • FaZe Holdings Inc. (NASDAQ: FAZE) dropped 14.2% to $12.66.
  • Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares fell 14.1% to $6.15. Kiora Pharmaceuticals said its stockholders authorized a reverse stock split of its common stock.
  • SAI.TECH Global Corporation (NASDAQ: SAI) dropped 14.1% to $4.10.
  • Midatech Pharma plc (NASDAQ: MTP) fell 14% to $2.2365.
  • Minerva Surgical, Inc. (NASDAQ: UTRS) dipped 13.8% to $0.7320.
  • Provident Financial (LON:PFG) Services, Inc. (NYSE: PFS) fell 12.5% to $20.27. Provident Financial Services and Lakeland Bancorp to merge in an all-stock transaction.
  • 374Water, Inc. (NASDAQ: SCWO) dropped 12.1% to $3.03.
  • Golden Sun Education Group Limited (NASDAQ: GSUN) fell 11.6% to $36.00.
  • Kronos Worldwide, Inc. (NYSE: KRO) dropped 11.2% to $9.48. Barclays (LON:BARC) maintained Kronos Worldwide with an Underweight and lowered the price target from $15 to $8.
  • Inpixon (NASDAQ: INPX) fell 10.4% to $0.1260. Inpixon shares jumped over 21% on Monday after the company announced it signed a definitive merger agreement with KINS Technology for KINS to acquire Inpixon's enterprise apps business.
  • Ocular Therapeutix, Inc. (NASDAQ: OCUL) dropped 10.5% to $4.7250. Ocular Therapeutix announced interim 7-month data from its U.S. Phase 1 trial evaluating OTX-TKI for wet age-related macular degeneration (wet AMD) and other retinal diseases.
  • AMTD Digital Inc. (NYSE: HKD) shares fell 8.9% to $59.22.
  • Troika Media Group, Inc. (NASDAQ: TRKA) shares fell 8.5% to $0.3453 after declining 6% on Monday.
  • HeartCore Enterprises, Inc. (NASDAQ: HTCR) dropped 7.9% to $1.05.
  • Studio City International Holdings Limited (NYSE: MSC) fell 6.9% to $2.28.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email